 Dopamine Uptake Inhibitors
"Dopamine Uptake Inhibitors" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Drugs that block the transport of DOPAMINE into axon terminals or into storage vesicles within terminals. Most of the ADRENERGIC UPTAKE INHIBITORS also inhibit dopamine uptake.
| Descriptor ID |
D018765
|
| MeSH Number(s) |
D27.505.519.625.150.800 D27.505.519.625.600.220 D27.505.696.577.150.800 D27.505.696.577.600.220
|
| Concept/Terms |
Dopamine Uptake Inhibitors- Dopamine Uptake Inhibitors
- Reuptake Inhibitors, Dopamine
- Inhibitors, Dopamine Uptake
- Uptake Inhibitors, Dopamine
- Inhibitors, Dopamine Reuptake
- Dopamine Reuptake Inhibitors
|
Below are MeSH descriptors whose meaning is more general than "Dopamine Uptake Inhibitors".
Below are MeSH descriptors whose meaning is more specific than "Dopamine Uptake Inhibitors".
This graph shows the total number of publications written about "Dopamine Uptake Inhibitors" by people in UAMS Profiles by year, and whether "Dopamine Uptake Inhibitors" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2020 | 1 | 1 | 2 | | 2019 | 1 | 2 | 3 | | 2018 | 1 | 0 | 1 | | 2016 | 1 | 0 | 1 | | 2015 | 1 | 1 | 2 | | 2014 | 1 | 1 | 2 | | 2013 | 3 | 0 | 3 | | 2011 | 4 | 0 | 4 | | 2009 | 2 | 2 | 4 | | 2008 | 3 | 0 | 3 | | 2007 | 1 | 0 | 1 | | 2006 | 3 | 2 | 5 | | 2005 | 4 | 0 | 4 | | 2004 | 0 | 3 | 3 | | 2003 | 1 | 1 | 2 | | 2002 | 2 | 0 | 2 | | 2001 | 2 | 0 | 2 | | 2000 | 2 | 0 | 2 |
To return to the timeline, click here.
Below are the most recent publications written about "Dopamine Uptake Inhibitors" by people in Profiles over the past ten years.
-
Soto PL, Hiranita T. Effects of benztropine analogs on delay discounting in rats. Psychopharmacology (Berl). 2020 Dec; 237(12):3783-3794.
-
McClenahan SJ, Gunnell MG, Owens SM, Fantegrossi WE. Active vaccination reduces reinforcing effects of MDPV in male Sprague-Dawley rats trained to self-administer cocaine. Psychopharmacology (Berl). 2020 Sep; 237(9):2613-2620.
-
Alzghoul BN, Abualsuod A, Alqam B, Innabi A, Palagiri DR, Gheith Z, Amer FN, Meena NK, Kenchaiah S. Cocaine Use and Pulmonary Hypertension. Am J Cardiol. 2020 01 15; 125(2):282-288.
-
Hyatt WS, Berquist MD, Chitre NM, Russell LN, Rice KC, Murnane KS, Fantegrossi WE. Repeated administration of synthetic cathinone 3,4-methylenedioxypyrovalerone persistently increases impulsive choice in rats. Behav Pharmacol. 2019 10; 30(7):555-565.
-
Lee NR, Zheng G, Leggas M, Janganati V, Nickell JR, Crooks PA, Bardo MT, Dwoskin LP. GZ-11608, a Vesicular Monoamine Transporter-2 Inhibitor, Decreases the Neurochemical and Behavioral Effects of Methamphetamine. J Pharmacol Exp Ther. 2019 11; 371(2):526-543.
-
Gannon BM, Baumann MH, Walther D, Jimenez-Morigosa C, Sulima A, Rice KC, Collins GT. The abuse-related effects of pyrrolidine-containing cathinones are related to their potency and selectivity to inhibit the dopamine transporter. Neuropsychopharmacology. 2018 11; 43(12):2399-2407.
-
Joolakanti SR, Nickell JR, Janganati V, Zheng G, Dwoskin LP, Crooks PA. Lobelane analogues containing 4-hydroxy and 4-(2-fluoroethoxy) aromatic substituents: Potent and selective inhibitors of [(3)H]dopamine uptake at the vesicular monoamine transporter-2. Bioorg Med Chem Lett. 2016 05 15; 26(10):2422-2427.
-
Goitia B, Rivero-Echeto MC, Weisstaub NV, Gingrich JA, Garcia-Rill E, Bisagno V, Urbano FJ. Modulation of GABA release from the thalamic reticular nucleus by cocaine and caffeine: role of serotonin receptors. J Neurochem. 2016 Feb; 136(3):526-35.
-
González CR, González B, Matzkin ME, Muñiz JA, Cadet JL, Garcia-Rill E, Urbano FJ, Vitullo AD, Bisagno V. Psychostimulant-Induced Testicular Toxicity in Mice: Evidence of Cocaine and Caffeine Effects on the Local Dopaminergic System. PLoS One. 2015; 10(11):e0142713.
-
Ziu E, Hadden C, Li Y, Lowery CL, Singh P, Ucer SS, Mercado CP, Gu HH, Kilic F. Effect of serotonin on platelet function in cocaine exposed blood. Sci Rep. 2014 Aug 05; 4:5945.
-
Kohut SJ, Hiranita T, Hong SK, Ebbs AL, Tronci V, Green J, Garcés-Ramírez L, Chun LE, Mereu M, Newman AH, Katz JL, Tanda G. Preference for distinct functional conformations of the dopamine transporter alters the relationship between subjective effects of cocaine and stimulation of mesolimbic dopamine. Biol Psychiatry. 2014 Nov 15; 76(10):802-9.
-
Meyer AC, Neugebauer NM, Zheng G, Crooks PA, Dwoskin LP, Bardo MT. Effects of VMAT2 inhibitors lobeline and GZ-793A on methamphetamine-induced changes in dopamine release, metabolism and synthesis in vivo. J Neurochem. 2013 Oct; 127(2):187-98.
-
Horton DB, Nickell JR, Zheng G, Crooks PA, Dwoskin LP. GZ-793A, a lobelane analog, interacts with the vesicular monoamine transporter-2 to inhibit the effect of methamphetamine. J Neurochem. 2013 Oct; 127(2):177-86.
-
Ding D, Nickell JR, Deaciuc AG, Penthala NR, Dwoskin LP, Crooks PA. Synthesis and evaluation of novel azetidine analogs as potent inhibitors of vesicular [3H]dopamine uptake. Bioorg Med Chem. 2013 Nov 01; 21(21):6771-7.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|